Dean Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
Dean Capital Management's HAE Position: Q3 2024 in Review
Dean Capital Management sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 8,088 shares — an estimated $669K sold.
Dean Capital Management first reported a position in HAE in Q2 2014 and held it in 15 quarters. The position peaked at $912K in Q2 2021. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.
- Dean Capital Management reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
- Dean Capital Management sold 8,088 Haemonetics shares in Q3 2024, an estimated $669K.
- Dean Capital Management first reported a position in Haemonetics in Q2 2014 and held it in 15 quarters.
- Dean Capital Management's Haemonetics position peaked at $912K in Q2 2021.
- 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.
Based on Dean Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.